Ozempic no replacement for willpower when it comes to weight loss
Gilles Mingasson/Getty Images
Chubby checkers
Which brings us back to the meta-study. One of the central unanswered questions surrounding these drugs is what happens when patients stop taking them. Does the weight stay off — or does it return?
In practice, many people don’t stay on them long. Roughly half of users discontinue weight-loss drugs within a year, most often citing cost and side effects, which can include severe gastrointestinal distress, vision problems, and — in rare cases — death.
What happens after discontinuation matters enormously. If the weight returns, many users will be forced to remain on these drugs indefinitely — possibly for decades — to avoid relapse. Pharmaceutical executives have generally been reluctant to acknowledge this implication, though some have done so candidly.
Habit-forming
The researchers behind the new meta-study asked a sharper question still: How does stopping weight-loss drugs compare with stopping traditional interventions like diet and exercise?
The answer is stark. People who stop taking weight-loss drugs regain weight at an average rate of 0.4 kilograms per month — roughly 10 pounds per year. That is four times faster than the weight regain seen in people who stop exercising and restricting calories.
Four times.
The explanation is not mysterious. Pills do not build habits. Diet and exercise do. With drugs, appetite suppression is outsourced to chemistry rather than cultivated through discipline. Remove the compound, and users are left with the same reserves of willpower they had before. Evidence so far suggests that changes to brain chemistry, hormone signaling, and metabolism fade along with the drug itself.
Even when people who diet and exercise relapse, the habits they developed tend to soften the fall. That counts for something.
None of this is to deny that weight-loss drugs can be a valuable tool. For many severely obese people, they may represent the only realistic chance of meaningful weight reduction. If we want to reduce the burden of chronic disease, drugs like Wegovy will have a role to play.
But their rise should not excuse the abandonment of harder truths. Sustainable weight loss still depends on choices, habits, and character — and on reshaping a food environment that makes bad choices effortless and good ones rare. Pharmaceuticals may assist that work. They cannot replace it.
Leave a Reply
You must be logged in to post a comment.